Immune system B-cells may be better in predicting HER2-positive breast cancer treatme

[News]

Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have found that measuring activation of immune-system B cells may be better than measuring either T-cell activation or the total number of immune cells in and around a tumor, called tumor-infiltrating lymphocytes (TILs), in predicting whether HER2-positive breast cancer responds to treatment.

More... (https://www.news-medical.net/news/20230105/Immune-system-B-cells-may-be-better-in-predicting-HER2-positive-breast-cancer-treatment-response.aspx)